Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-01-31 4:38 pm |
N/A 2035-01-30 |
Contineum Therapeutics Inc. | CTNM | Huhn Stephen L. CMO & Sr VP, Clinical Dev. |
110,000 | $0 | 110,000 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-14 6:03 pm |
N/A N/A |
Contineum Therapeutics Inc. | CTNM | Huhn Stephen L. CMO & Sr VP, Clinical Dev. |
12,800 | $1.01 | 174,194 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-14 6:03 pm |
N/A 2030-02-24 |
Contineum Therapeutics Inc. | CTNM | Huhn Stephen L. CMO & Sr VP, Clinical Dev. |
12,800 | $0 | 174,194 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 5:56 pm |
N/A 2034-05-23 |
Contineum Therapeutics Inc. | CTNM | Huhn Stephen L. CMO & Sr VP, Clinical Dev. |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2024-04-04 5:54 pm |
N/A 2030-02-24 |
Contineum Therapeutics Inc. | CTNM | Huhn Stephen L. CMO & Sr VP, Clinical Dev. |
0 | $0 | 236,725 (Direct) |
View |